- Home
- RANGU vs KROS Comparison
RANGU vs KROS Comparison
Compare RANGU & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RANGU
- KROS
- Stock Information
- Founded
- RANGU N/A
- KROS 2015
- Country
- RANGU United States
- KROS United States
- Employees
- RANGU N/A
- KROS 163
- Industry
- RANGU
- KROS Biotechnology: Pharmaceutical Preparations
- Sector
- RANGU
- KROS Health Care
- Exchange
- RANGU Nasdaq
- KROS Nasdaq
- Market Cap
- RANGU N/A
- KROS 558.9M
- IPO Year
- RANGU N/A
- KROS 2020
- Fundamental
- Price
- RANGU $10.70
- KROS $13.35
- Analyst Decision
- RANGU
- KROS Buy
- Analyst Count
- RANGU 0
- KROS 13
- Target Price
- RANGU N/A
- KROS $20.63
- AVG Volume (30 Days)
- RANGU N/A
- KROS 620.1K
- Earning Date
- RANGU N/A
- KROS 08-06-2025
- Dividend Yield
- RANGU N/A
- KROS N/A
- EPS Growth
- RANGU N/A
- KROS N/A
- EPS
- RANGU N/A
- KROS 0.11
- Revenue
- RANGU N/A
- KROS $214,713,000.00
- Revenue This Year
- RANGU N/A
- KROS $5,006.76
- Revenue Next Year
- RANGU N/A
- KROS N/A
- P/E Ratio
- RANGU N/A
- KROS $123.16
- Revenue Growth
- RANGU N/A
- KROS 91657.70
- 52 Week Low
- RANGU N/A
- KROS $9.12
- 52 Week High
- RANGU N/A
- KROS $72.37
- Technical
- Relative Strength Index (RSI)
- RANGU N/A
- KROS 43.06
- Support Level
- RANGU N/A
- KROS $13.41
- Resistance Level
- RANGU N/A
- KROS $13.99
- Average True Range (ATR)
- RANGU 0.00
- KROS 0.44
- MACD
- RANGU 0.00
- KROS -0.07
- Stochastic Oscillator
- RANGU 0.00
- KROS 9.84
About RANGU Range Capital Acquisition Corp. Units
Range Capital Acquisition Corp is a blank check company.
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.